News Item

Nov 1, 2021
These Five Companies Are Changing the Pharma Industry Through Liposomes

The Science Times

The liposome drug delivery devices market, currently valued at $3.64 billion, is expected to hit $5.30 billion by 2025 (10% CAGR). The growth is fueled by several factors, including economic growth and increased healthcare expenditure in emerging markets, an expanding elderly population needing advanced healthcare, and an increased number of research and innovation-driven pharmaceuticals.